Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-vitrectomy NSAID versus steroid eye drops recovery study
2024-518807-23-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diclofenac, dexamethasone and triamcinolone acetonide in Full Thickness Macular Hole (FTMH), vitreomacular traction (VMT) and chorioretinal scar (2 arms), sponsored by UZ Leuven. Primary endpoint: Incidence of intraocular pressure increase. Started Sep 2025; status: completed.
02
Drugs
diclofenacdexamethasonetriamcinolone acetonide
03
Conditions
Full Thickness Macular Hole (FTMH)vitreomacular traction (VMT)chorioretinal scar
Beyond the preview
Go deeper on 2024-518807-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518807-23-00.